Anna Fogdell‐Hahn

Affibody (Sweden) — Sweden

Medicine · Health Sciences

35h-index4.1kcitations145works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(50), Multiple Sclerosis Research Studies(46), Cytomegalovirus and herpesvirus research(30), Polyomavirus and related diseases(28), Systemic Lupus Erythematosus Research(23)

Publications145 total

Use of antiviral medications during pregnancy and the likelihood of preeclampsia in a population-based register study
Scientific Reports·2025Open Access
Multiple Sclerosis
2024
<scp>COMBAT</scp>‐<scp>MS</scp>: A Population‐Based Observational Cohort Study Addressing the Benefit–Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab
Annals of Neurology·2024· 12 citedOpen Access
Comparing the Safety and Effectiveness of Different Medicines to Treat Multiple Sclerosis – The COMBAT-MS Study
2023· 1 citedOpen Access
Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis
Brain·2023· 22 citedOpen Access
Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy
Journal of Neurology Neurosurgery & Psychiatry·2023· 10 citedOpen Access
Comparing the Safety of Medicines to Treat MS during the COVID-19 Pandemic
2023Open Access
COVID-19–Related Enhancement for the COMBAT-MS Study
2023
Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort
Multiple Sclerosis and Related Disorders·2022· 13 citedOpen Access
Anti-rituximab antibodies demonstrate neutralizing capacity, associate with lower circulating drug levels and earlier relapse in lupus
Lara D. Veeken·2022· 23 citedOpen Access
PO.6.126 Anti-rituximab antibodies demonstrate neutralising capacity, associate with lower circulating drug levels and early relapse in patients undergoing treatment for systemic lupus erythematosus
2022Open Access
<scp>COVID</scp>‐19 clinical outcomes and <scp>DMT</scp> of <scp>MS</scp> patients and population‐based controls
Annals of Clinical and Translational Neurology·2022· 17 citedOpen Access
Longitudinal analysis of anti-drug antibody development in multiple sclerosis patients treated with interferon beta-1a (Rebif™) using B cell receptor repertoire analysis
Journal of Neuroimmunology·2022· 4 citedOpen Access
Serum IgG levels to Epstein-Barr and measles viruses in patients with multiple sclerosis during natalizumab and interferon beta treatment
BMJ Neurology Open·2022· 13 citedOpen Access
A Genetic Association Test Accounting for Skewed X-Inactivation With Application to Biotherapy Immunogenicity in Patients With Autoimmune Diseases
Frontiers in Medicine·2022· 1 citedOpen Access
Mo1528: INFLIXIMAB PEAK AND 1-WEEK SERUM LEVEL ESTIMATES PREDICT 8-WEEK TROUGH LEVELS IN INFLAMMATORY BOWEL DISEASE
Gastroenterology·2022
P243 Anti-rituximab antibodies demonstrate neutralising capacity, associate with lower circulating drug levels and early relapse in patients undergoing treatment for systemic lupus erythematosus
Lara D. Veeken·2022· 1 citedOpen Access
Short report: Real-life analysis of the occurrence of persistent, transient, and fluctuating positive titres of neutralizing anti-drug antibodies in multiple sclerosis patients treated with interferon beta
Multiple Sclerosis and Related Disorders·2022
Rituximab in Systemic Lupus Erythematosus: Transient Effects on Autoimmunity Associated Lymphocyte Phenotypes and Implications for Immunogenicity
Frontiers in Immunology·2022· 35 citedOpen Access
Physical exercise is associated with a reduction in plasma levels of fractalkine, TGF-β1, eotaxin-1 and IL-6 in younger adults with mobility disability
PLoS ONE·2022· 15 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Jan Hillert(15), Tomas Olsson(13), Nicky Dunn(9), Malin Ryner(9), Elin Engdahl(7), Ingrid Kockum(7), Florian Deisenhammer(7), Clemens Warnke(7), Steven Jacobson(6), Rasmus Gustafsson(6), Philippe Broët(6), Bernd C. Kieseier(6), Pierre Dönnes(6), Katharina Fink(5), Malin Lundkvist(5), Marc Pallardy(5), Elizabeth C. Jury(5), Signe Hässler(5), Nastya Kharlamova(5), Martin Gunnarsson(4)